| ¡@ |
| Epitomics and Roche Enter Rabbit Monoclonal Antibody Technology Research Agreement. |
| 10/18/2005 |
|
Epitomics, Inc. announced a research agreement granting Roche a license to Epitomics' rabbit monoclonal antibody technology (RabMab technology) for the discovery and development of monoclonal antibodies to treat cancer and other diseases.
Epitomics¡¦ unique approach utilizes monoclonal antibodies from rabbits, potentially improving the quality and efficiency of drug discovery. Epitomics will receive event payments and future royalties on worldwide sales of products developed from RabMab technology. PACK-LINK BioVentures invested in Epitomics, Inc. |
| ¡@ |
¡@ |
¡@ |
